Posts With Tag NYSE LLY

Showing 1 - 2 of 2 Posts

Eli Lilly & Co. 8-K Report: Insights on Debt Instruments and Financial Obligations

•

Form 8-K

•

2025-02-12

Last updated: 3 months ago

Eli Lilly & Co. 8-K Report: Insights on Debt Instruments and Financial Obligations

Explore Eli Lilly & Co.'s February 2025 8-K report detailing various debt instruments, interest rates, and equity structure. Key insights for investors and financial analysts.

Eli Lilly & Co.pharmaceuticals debt instruments financial reporting NYSE LLY

Eli Lilly 8-K Report: Key Financial Insights & Debt Obligations as of Jan 14, 2025

•

Form 8-K

•

2025-01-14

Last updated: 4 months ago

Eli Lilly 8-K Report: Key Financial Insights & Debt Obligations as of Jan 14, 2025

Explore Eli Lilly's 8-K filing detailing debt instruments, stock info, and corporate data effective January 14, 2025. Key insights for investors and stakeholders.

Eli Lilly and Company pharmaceuticals debt instruments financial reporting NYSE LLY